68 related articles for article (PubMed ID: 27460008)
41. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
42. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
[TBL] [Abstract][Full Text] [Related]
43. Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells.
Chang LH; Chen CH; Huang DY; Pai HC; Pan SL; Teng CM
J Cell Physiol; 2011 Apr; 226(4):1060-8. PubMed ID: 20857420
[TBL] [Abstract][Full Text] [Related]
44. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells.
Jeong YJ; Choi Y; Shin JM; Cho HJ; Kang JH; Park KK; Choe JY; Bae YS; Han SM; Kim CH; Chang HW; Chang YC
Food Chem Toxicol; 2014 Jun; 68():218-25. PubMed ID: 24675423
[TBL] [Abstract][Full Text] [Related]
45. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
[TBL] [Abstract][Full Text] [Related]
46. Synergistic Effect of TPD7 and Berberine against Leukemia Jurkat Cell Growth through Regulating Ephrin-B2 Signaling.
Ma W; Zhu M; Yang L; Yang T; Zhang Y
Phytother Res; 2017 Sep; 31(9):1392-1399. PubMed ID: 28703366
[TBL] [Abstract][Full Text] [Related]
47. Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment.
Korff T; Braun J; Pfaff D; Augustin HG; Hecker M
Blood; 2008 Jul; 112(1):73-81. PubMed ID: 18445690
[TBL] [Abstract][Full Text] [Related]
48. Proangiogenic effect and underlying mechanism of holmium oxide nanoparticles: a new biomaterial for tissue engineering.
Luo Y; Zheng Y; Chen Z; Mo M; Xie J; Zhou X; Wu Y; Yang Q; Zheng M; Hu X; Chen L; Lan Z
J Nanobiotechnology; 2024 Jun; 22(1):357. PubMed ID: 38902755
[TBL] [Abstract][Full Text] [Related]
49. EphrinB2 controls vessel pruning through STAT1-JNK3 signalling.
Salvucci O; Ohnuki H; Maric D; Hou X; Li X; Yoon SO; Segarra M; Eberhart CG; Acker-Palmer A; Tosato G
Nat Commun; 2015 Mar; 6():6576. PubMed ID: 25807892
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of EphB6 and EphrinB2 controls soma spacing of cortical neurons in a mutual inhibitory way.
He CH; Song NN; Xie PX; Wang YB; Chen JY; Huang Y; Hu L; Li Z; Su JH; Zhang XQ; Zhang L; Ding YQ
Cell Death Dis; 2023 May; 14(5):309. PubMed ID: 37149633
[TBL] [Abstract][Full Text] [Related]
51. Atorvastatin regulates pericardial patch healing via the microRNA140-ADAM10-ephrinB2 pathway.
Li X; Dardik A; Guo R; Zhang W; Xiang Y; Li S; Liu D; Shu C
Am J Transl Res; 2018; 10(12):4054-4064. PubMed ID: 30662650
[No Abstract] [Full Text] [Related]
52. PICK1 modulates glycolysis and angiogenesis of hypoxic endothelial cells by regulating iron homeostasis.
Cao Y; Wang H; Hu S; Xu Q; Ma J; Wang H; Xiong X; Wang W; Wang L
Mol Cell Biochem; 2024 May; 479(5):1297-1312. PubMed ID: 37368155
[TBL] [Abstract][Full Text] [Related]
53. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I; Karniadakis I; Danos KS; Vrettou K; Michaelidou K; Mavridis K; Agelaki S; Theocharis S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613532
[TBL] [Abstract][Full Text] [Related]
54. Taspine derivative 12k suppressed A549 cell migration through the Wnt/β-catenin and EphrinB2 signaling pathway.
Dai B; Ma Y; Yang T; Wang W; Zhang Y
Biomed Pharmacother; 2017 Mar; 87():102-109. PubMed ID: 28049091
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways.
Liu R; Yu R; Cui Y; Fan M; Wang B; Zhang Y
Acta Pharm; 2019 Sep; 69(3):423-431. PubMed ID: 31259732
[TBL] [Abstract][Full Text] [Related]
56. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
57. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
58. Targeting the PI3K/Akt/mTOR pathway in ocular neovascularization.
Sasore T; Reynolds AL; Kennedy BN
Adv Exp Med Biol; 2014; 801():805-11. PubMed ID: 24664774
[TBL] [Abstract][Full Text] [Related]
59. A taspine derivative supresses Caco-2 cell growth by competitively targeting EphrinB2 and regulating its pathway.
Dai B; Wang W; Ma Y; Liu R; Zhang Y
Oncol Rep; 2016 Sep; 36(3):1526-34. PubMed ID: 27460008
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
